Residual Isocyanates in Medical Devices and Products: A Qualitative and Quantitative Assessment

A novel treatment and derivatization for quantification of residual aromatic diisocyanates in polyamide resins

In the scientific context, the environmental and healthy impact of polymers is more related to the residual monomer content rather than their macromolecular structure, due to the monomer capability to interact with membrane cells. For this a novel method to stabilize and quantify residual monomeric isocyanates in high thermal resistance polyamide resins (PAs) has been developed. This new analytical method resulted in an improvement concerning the quantification of residual aromatic diisocyanates in viscous polymeric matrices by using a simple and cheap technique like HPLC-VWD. Diisocyanate monomers were derivatized with dibutylamine, resulting in stable urea derivatives that were simultaneously analysed and quantified. The method was applied to solvent-based polyamide resins, used as primary electrical insulation, for avoiding additional step of solvent removing before the analysis. The quantification of residual monomers answers to the provisions imposed by European Regulation N. 1907/2006 (REACH) for polymer registration, and the necessity of an early evaluation of the occupational risk associated with the use of diisocyanates, due to their toxicity and high reactivity towards moisture.

Recent developments in etiology and disease modeling of biliary atresia: a narrative review

Biliary atresia (BA) is a rare but severe fibroinflammatory disease of the extrahepatic and the intrahepatic bile ducts. Without prompt interventions, BA has fatal outcomes and is the most common indicator for pediatric liver transplantation (LTx). While the mainstay of treatment involves surgically correcting the extrahepatic biliary obstruction via Kasai hepato-portoenterostomy (KHPE), activation of a multitude of biological pathways and yet-to-be-determined etiology in BA continue to foster liver inflammation, cirrhosis and need for LTx. However, important caveats still exist in our understandings of the biliary pathophysiology, the rapidity of liver fibrosis and progression to liver failure, largely due to limited knowledge of the triggers of biliary injury and the inability to accurately model human BA. Although inconclusive, a large body of existing literature points to a potential viral infection in the early peri- or postnatal period as triggers of epithelial injury that perpetuates the downstream biliary disease. Further confounding this issue, are the lack of in-vivo and in-vitro models to efficiently recapitulate the cardinal features of BA, primarily liver fibrosis. To overcome these barriers in BA research, new directions in recent years have enabled (I) identification of additional triggers of biliary injury linked mostly to environmental toxins, (II) development of models to investigate liver fibrogenesis, and (III) translational research using patient-derived organoids. Here, we discuss recent advances that undoubtedly will stimulate future efforts investigating these new and exciting avenues towards mechanistic and drug discovery efforts and disease-preventive measures. The implications of these emerging scientific investigations and disease modeling in severe fibrosing cholangiopathies like BA are enormous and contribute substantially in our understandings of this rare but deadly disease. These findings are also expected to facilitate expeditious identification of translationally targetable pathways and bring us one step closer in treating an infant with BA, a population highly vulnerable to life-long liver related complications.

Azido-Functionalized Polyurethane Designed for Making Tunable Elastomers by Click Chemistry

Polyurethane is an important biomaterial with wide applications in biomedical engineering. Here, we report a new method to make an azido-functionalized polyurethane prepolymer with no need of postmodification. This prepolymer can easily form stable porous elastomers through click chemistry for cross-linking, instead of using a toxic polyisocyanate. The mechanical properties can be modulated by simply adjusting either the prepolymer concentrations or azido/alkyne ratios for cross-linking. Young's modulus therefore varies from 0.52 to 2.02 MPa for the porous elastomers. When the azido-functionalized polyurethane elastomer is made with a compact structure, Young's modulus increases up to 28.8 MPa at 0-15% strain. The strain at break reaches 150% that is comparable to the commercially resourced Nylon-12. Both the porous and compact elastomers could undergo reversible elastic deformations for at least 200 and 1000 cycles, respectively, within 20% strain without failure. The material showed a considerable stability against erosion in a basic solution. In vivo biocompatibility study demonstrated no degradation by subcutaneous implantation in mice over 2 months. The implant induced only a mild inflammatory response and fibrotic capsule. This material might be useful to make elastomeric components of biomedical devices.